Gene · 923
Papers1,942
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 1,942
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| rs12329760 Polymorphism in Transmembrane Serine Protease 2 Gene and Risk of Coronavirus Disease 2019 Mortality. | Biomed Res Int | 2022 | 36457338 | PubTator, text mining | PubMed |
| The combination of SMRT sequencing and Illumina sequencing highlights organ-specific and age-specific expression patterns of miRNAs in Sika Deer. | Front Vet Sci | 2022 | 36452144 | PubTator, text mining | PubMed |
| Analysis of herpesvirus infection and genome single nucleotide polymorphism risk factors in multiple sclerosis, Volga federal district, Russia. | Front Immunol | 2022 | 36451826 | PubTator, text mining | PubMed |
| Immune-based classification of HPV-associated oropharyngeal cancer with implications for biomarker-driven treatment de-intensification. | EBioMedicine | 2022 | 36442320 | PubTator, text mining | PubMed |
| CD6-mediated inhibition of T cell activation via modulation of Ras. | Cell Commun Signal | 2022 | 36414966 | PubTator, text mining | PubMed |
| Intermuscular adipose tissue in patients with systemic lupus erythematosus. | Lupus Sci Med | 2022 | 36414333 | PubTator, text mining | PubMed |
| Differential Circular RNA Expression Profiling of Orbital Connective Tissue From Patients With Type I and Type II Thyroid-Associated Ophthalmopathy. | Invest Ophthalmol Vis Sci | 2022 | 36409215 | PubTator, text mining | PubMed |
| Alzheimer's disease alters the transcriptomic profile of natural killer cells at single-cell resolution. | Front Immunol | 2022 | 36405736 | PubTator, text mining | PubMed |
| Is subcutaneous adipose tissue expansion in people living with lipedema healthier and reflected by circulating parameters? | Front Endocrinol (Lausanne) | 2022 | 36387874 | PubTator, text mining | PubMed |
| RNA Metabolism in T Lymphocytes. | Immune Netw | 2022 | 36381959 | PubTator, text mining | PubMed |
| Single-cell analysis of multiple myelomas refines the molecular features of bortezomib treatment responsiveness. | Exp Mol Med | 2022 | 36380017 | PubTator, text mining | PubMed |
| Immune biomarkers of response to immunotherapy in patients with high-risk smoldering myeloma. | Cancer Cell | 2022 | 36379208 | PubTator, text mining | PubMed |
| Roles of physical exercise-induced MiR-126 in cardiovascular health of type 2 diabetes. | Diabetol Metab Syndr | 2022 | 36376958 | PubTator, text mining | PubMed |
| Biomarkers in Systemic Juvenile Idiopathic Arthritis, Macrophage Activation Syndrome and Their Importance in COVID Era. | Int J Mol Sci | 2022 | 36361547 | PubTator, text mining | PubMed |
| Keratinocyte-induced costimulation of human T cells through CD6 - but not CD2 - activates mTOR and prevents oxidative stress. | Front Immunol | 2022 | 36353616 | PubTator, text mining | PubMed |
| Network reconstruction for trans acting genetic loci using multi-omics data and prior information. | Genome Med | 2022 | 36344995 | PubTator, text mining | PubMed |
| Autoantibodies - enemies, and/or potential allies? | Front Immunol | 2022 | 36341384 | PubTator, text mining | PubMed |
| An immune dysfunction score for stratification of patients with acute infection based on whole-blood gene expression. | Sci Transl Med | 2022 | 36322631 | PubTator, text mining | PubMed |
| Efficacy and safety of polyherbal formulation as an add-on to standard-of-care in mild-to-moderate COVID-19: A randomized, double-blind, placebo-controlled trial. | J Ayurveda Integr Med | 2022 | 36311474 | PubTator, text mining | PubMed |
| Characterization of the tumour microenvironment phenotypes in malignant tissues and pleural effusion from advanced osteoblastic osteosarcoma patients. | Clin Transl Med | 2022 | 36305631 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/923/papers?page=19